One or two points about that first Observer article, because that blame-the-bloggers not-pology is so annoying.
One, Stephen Pritchard wrote yesterday, truculently,
that concern should have been in the article, but because it was absent doesn’t mean that the paper was promoting the treatment, as some have suggested (“pimping” it, as one science writer so crudely tweeted).
No, the fact that the concern was absent doesn’t mean that the paper was promoting the treatment, but all the same, the paper (via the article) was to some extent promoting the treatment. Bainbridge called it “a pioneering treatment” when it’s a trial rather than a treatment, and “pioneering” makes it sound new and potentially promising as opposed to more than 30 … Read the rest
(This is a syndicated post. Read the original at FreeThoughtBlogs.)